UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Role of non-coding sequence variants in cancer

Nature reviews. Genetics, 2016-02, Vol.17 (2), p.93

2016

Link zum Volltext

Verfügbarkeit prüfen

N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

Cancer cell, 2016-10, Vol.30 (4), p.563-577

2016

Link zum Volltext

Verfügbarkeit prüfen

Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

Nature (London), 2018-08, Vol.560 (7719), p.499-503

2018

Link zum Volltext

Verfügbarkeit prüfen

Biology and evolution of poorly differentiated neuroendocrine tumors

Nature medicine, 2017-06, Vol.23 (6), p.1-673

2017

Link zum Volltext

Verfügbarkeit prüfen

Loss and revival of androgen receptor signaling in advanced prostate cancer

Oncogene, 2021-02, Vol.40 (7), p.1205-1216

2021

Link zum Volltext

Verfügbarkeit prüfen

Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function

Molecular cell, 2015-06, Vol.58 (6), p.925-934

2015

Link zum Volltext

Verfügbarkeit prüfen

Common Gene Rearrangements in Prostate Cancer

Journal of clinical oncology, 2011-09, Vol.29 (27), p.3659-3668

2011

Link zum Volltext

Verfügbarkeit prüfen

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

Nature medicine, 2016-03, Vol.22 (3), p.298-305

2016

Link zum Volltext

Verfügbarkeit prüfen

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical cancer research, 2014-06, Vol.20 (11), p.2846-2850

2014

Link zum Volltext

Verfügbarkeit prüfen

Clonal evolution of chemotherapy-resistant urothelial carcinoma

Nature genetics, 2016-12, Vol.48 (12), p.1490-1499

2016

Link zum Volltext

Verfügbarkeit prüfen

Beyond PSA: the next generation of prostate cancer biomarkers

Science translational medicine, 2012-03, Vol.4 (127), p.127rv3

2012

Link zum Volltext

Verfügbarkeit prüfen

Genomic Correlates to the Newly Proposed Grading Prognostic Groups for Prostate Cancer

European urology, 2016-04, Vol.69 (4), p.557-560

2016

Link zum Volltext

Verfügbarkeit prüfen

Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer

Cancer discovery, 2017-07, Vol.7 (7), p.736-749

2017

Link zum Volltext

Verfügbarkeit prüfen

The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors

European urology, 2022-11, Vol.82 (5), p.469-482

2022

Link zum Volltext

Verfügbarkeit prüfen

DNA Repair in Prostate Cancer: Biology and Clinical Implications

European urology, 2017-03, Vol.71 (3), p.417-425

2017

Link zum Volltext

Verfügbarkeit prüfen

Patient derived organoids to model rare prostate cancer phenotypes

Nature communications, 2018-06, Vol.9 (1), p.2404-10, Article 2404

2018

Link zum Volltext

Verfügbarkeit prüfen

Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer

Nature biotechnology, 2017-06, Vol.35 (6), p.577-582

2017

Link zum Volltext

Verfügbarkeit prüfen

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

Cell reports (Cambridge), 2015-08, Vol.12 (6), p.922-936

2015

Link zum Volltext

Verfügbarkeit prüfen

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

Cancer discovery, 2017-01, Vol.7 (1), p.54-71

2017

Link zum Volltext

Verfügbarkeit prüfen

The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance

Clinical cancer research, 2019-12, Vol.25 (23), p.6916-6924

2019

Link zum Volltext

Verfügbarkeit prüfen

SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling

Cancer cell, 2017-03, Vol.31 (3), p.436-451

2017

Link zum Volltext

Verfügbarkeit prüfen

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling

Nature communications, 2019-07, Vol.10 (1), p.2977-11, Article 2977

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.729

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.392)
Mit Volltextzugriff
(2.424)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.716)
Japanisch
(381)
Deutsch
(3)
Russisch
(2)
Spanisch
(1)
Norwegisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.525)
Life Sciences & Biomedicine
(1.371)
Humans
(1.304)
Male
(816)
Biological And Medical Sciences
(554)
Female
(524)
Medical Sciences
(497)
Middle Aged
(433)
Adult
(357)
Aged
(341)
Oncology
(315)
Animals
(263)
Tumors
(238)
Prostatic Neoplasms - Pathology
(212)
Prostatic Neoplasms - Genetics
(195)
Prostate Cancer
(182)
Mice
(143)
Nephrology. Urinary Tract Diseases
(139)
Social Sciences
(139)
Surgery
(136)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(137)
Chest
(65)
Journal Of Clinical Oncology
(51)
Neoplasia
(43)
Diabetes Care
(40)
Gastroenterology
(40)
The New England Journal Of Medicine
(37)
Plos One
(31)
Urology
(29)
Clinical Cancer Research
(28)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Role of non-coding sequence variants in cancer

N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

Biology and evolution of poorly differentiated neuroendocrine tumors

Loss and revival of androgen receptor signaling in advanced prostate cancer

Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function

Common Gene Rearrangements in Prostate Cancer

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

Aggressive Variants of Castration-Resistant Prostate Cancer

Clonal evolution of chemotherapy-resistant urothelial carcinoma

Beyond PSA: the next generation of prostate cancer biomarkers

Genomic Correlates to the Newly Proposed Grading Prognostic Groups for Prostate Cancer

Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors

DNA Repair in Prostate Cancer: Biology and Clinical Implications

Patient derived organoids to model rare prostate cancer phenotypes

Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance

SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling

Suchergebnisse filtern